Patient Presentation
2013 ACC/AHA Cholesterol Guidelines
4 Major Statin Benefit Groups
Timelines of Lipid-Lowering Agents
Evolution of Therapeutic Monoclonal Antibodies
PCSK9 Inhibition in Patients With Hypercholesterolemia Receiving
Statin Therapy
Effect of PCSK9-Inhibitor Monotherapy on Lipid Parameters
Clinical Considerations for PCSK9 Inhibitors
Abbreviations
Abbreviations (cont)
References
References (cont)
References (cont)
References (cont)
Top Related